Disease-Type-Aware Biological Intelligence Layers for Preventing Symptom Marker False Positives in Computational Drug Target Identification

Biological intelligence layers that distinguish causal disease drivers from symptom markers, eliminating a major class of false positives in computational target identification pipelines.